- Home
- XP vs ACHC Comparison
XP vs ACHC Comparison
Compare XP & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XP | ACHC |
|---|---|---|
| Founded | 2001 | 2005 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 1.1B |
| IPO Year | 2019 | 2011 |
Fundamental Metrics
Financial Performance| Metric | XP | ACHC |
|---|---|---|
| Price | $19.86 | $26.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 14 |
| Target Price | ★ $23.17 | $21.64 |
| AVG Volume (30 Days) | ★ 5.6M | 2.6M |
| Earning Date | 05-19-2026 | 05-11-2026 |
| Dividend Yield | ★ 0.97% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,312,769,000.00 |
| Revenue This Year | $18.72 | $5.08 |
| Revenue Next Year | $13.53 | $5.98 |
| P/E Ratio | $11.42 | ★ N/A |
| Revenue Growth | N/A | ★ 5.04 |
| 52 Week Low | $12.51 | $11.43 |
| 52 Week High | $23.13 | $28.93 |
Technical Indicators
Market Signals| Indicator | XP | ACHC |
|---|---|---|
| Relative Strength Index (RSI) | 54.30 | 69.59 |
| Support Level | $18.58 | $23.02 |
| Resistance Level | $20.46 | $27.50 |
| Average True Range (ATR) | 0.82 | 1.19 |
| MACD | 0.11 | 0.02 |
| Stochastic Oscillator | 79.32 | 96.59 |
Price Performance
Historical ComparisonAbout XP XP Inc.
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.
About ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.